Results 201 to 210 of about 27,040,870 (237)
High-voltage FinFET with floating poly and high-k material for enhanced intrinsic gain and safe operating area. [PDF]
Oh K +8 more
europepmc +1 more source
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source
201 | Repetitive Transcranial Magnetic Stimulation for Idiopathic Overactive Bladder: A Pilot Trial
K Ieong +4 more
doaj +1 more source
Photo-Curable Stretchable High-k Polymer/TiO<sub>2</sub> Nanosheet Hybrid Dielectrics for Field-Effect Transistors. [PDF]
Chen QG, Cai X, Chueh CC, Lee WY.
europepmc +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Proceedings of the International Conference on High Energy Collisions
International Conference on High Energy Collisions
core
Super High-k Dielectric via Composition-Dependent Hafnium Zirconium Oxide Superlattice for Si Nanosheet Gate-All-Around Field-Effect Transistors with NH<sub>3</sub> Plasma-Optimized Interfaces. [PDF]
Yao YJ +8 more
europepmc +1 more source
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
High-K dielectric sulfur-selenium alloys. [PDF]
Susarla S +20 more
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

